Tech Company Financing Transactions

Eigen Therapeutics Funding Round

Eigen Therapeutics closed a $7 million Seed funding round on 12/10/2022. Investors included private investors, Mount Pleasant Ventures and Alumni Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

740 Broadway
Redwood City, CA 94063
USA

Phone

Undisclosed

Website

www.eigentx.com

Email Address

[email protected]

Overview

Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of "priming" therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Transon Nguyen

        

Chief Scientific Officer

Kathryn Vanderlaag

        

Chief Technical Officer

Kamran Ali

        

Browse more venture capital transactions:

Prev: 12/9/2022: Hunt Club venture capital transaction
Next: 12/12/2022: AltScore venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to document all VC transactions involving tech companies. All VC database entries on this site come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary